• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EPOCAL INC. EPOC READER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EPOCAL INC. EPOC READER Back to Search Results
Catalog Number 10736398
Device Problem Non Reproducible Results (4029)
Patient Problem Insufficient Information (4580)
Event Date 11/12/2020
Event Type  malfunction  
Manufacturer Narrative
Siemens has completed the investigation: the cause of the hematocrit (hct) discrepancy could not be determined from the information provided by the customer.A review of the in-house performance (including retain testing) for the card lot used, 10-20216-20, did not identify any product deficiencies.The failure rate of lot 10-20216-20 is not showing an increased trend in the field, therefore, there is no further evidence that the system or reagent cards are not performing as intended.The csv files provided by the customer offered additional insights and brought value to the investigation.From the information provided by the customer, there are a few factors that may have contributed to a discrepant hct reading.Firstly, different sample draws (collection site, collection method, time delays), sample handling and testing delays are known to affect test results if proper precautions are not considered.On 12 nov 2020, it was indicated that the epoc sample was tested at 5:41 am, resulting in an iqc failure (sample delivery failure).The same sample was then tested again at 5:47 am on epoc (6 min delay), providing the hct result of 27 %pcv.It should be noted that delays in testing a drawn blood sample in the absence of anticoagulant increase the risk associated with clotting and mixing (sample handling) related issues - which in turn can lead to discrepant readings.Secondly, the methods of hct measurement are not the same with epoc and the comparative instrument.Sysmex uses a complete blood cell count (cbc) method, which has known limitations associated with the calculation of falsely elevated values when a high reticulocyte or white blood cell (wbc) count is present.This is because the higher cell volumes of wbcs/ reticulocytes can interfere with the rbc count and thus falsely increase the hct reading.The customer has confirmed the patient's reticulocyte count was slightly elevated and wbc count was high, therefore, the impact/contribution of this measurement method cannot be ruled out as a potential elevated result on the sysmex.Thirdly, it was indicated by the customer that the sysmex xn 3000 utilized a sample with k2 edta anticoagulant.It is well documented in literature that the mean cell volumes of k3 edta anticoagulated blood are approximately 4% less than k2 edta anticoagulated blood.While the choice of anticoagulant affects the microhematocrit method to which all hematocrit methods are calibrated, results from routine samples on hematology analyzers are independent of the anticoagulant used.Since most clinical hematology analyzers are calibrated by the microhematocrit method using k3 edta anticoagulant, the epoc system is calibrated to a k3 edta microhematocrit method.If the sysmex instrument is calibrated to k2 edta anticoagulated blood, it will read ~4% higher than epoc.In these situations epoc advises a correction factor of 1.045 (e.G.K2 edta sysmex / 1.045).
 
Event Description
The customer reported a discrepant hematocrit result on a neonate on the epoc reader when compared to the result on a non-siemens hematology instrument.There was no report of injury due to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPOC READER
Type of Device
EPOC
Manufacturer (Section D)
EPOCAL INC.
2060 walkley road
ottawa, ontario K1G 3 P5
CA  K1G 3P5
Manufacturer (Section G)
EPOCAL INC.
2060 walkley road
ottawa, ontario K1G 3 P5
CA   K1G 3P5
Manufacturer Contact
felix akinrinola
2 edgewater drive
norwood, MA 02062
6107052212
MDR Report Key10905601
MDR Text Key221012020
Report Number3002637618-2020-00067
Device Sequence Number1
Product Code CGL
UDI-Device Identifier00809708121860
UDI-Public00809708121860
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K113726
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number10736398
Date Manufacturer Received11/12/2020
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-